Results 111 to 120 of about 12,192,107 (344)

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Growth disorders caused by variants in epigenetic regulators: progress and prospects

open access: yesFrontiers in Endocrinology
Epigenetic modifications play an important role in regulation of transcription and gene expression. The molecular machinery governing epigenetic modifications, also known as epigenetic regulators, include non-coding RNA, chromatin remodelers, and enzymes
Julian C. Lui
doaj   +1 more source

Additional mitochondrial DNA influences the interactions between the nuclear and mitochondrial genomes in a bovine embryo model of nuclear transfer

open access: yesScientific Reports, 2018
We generated cattle embryos using mitochondrial supplementation and somatic cell nuclear transfer (SCNT), named miNT, to determine how additional mitochondrial DNA (mtDNA) modulates the nuclear genome.
Kanokwan Srirattana, Justin C. St. John
doaj   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Importance of DNA Sequencing for Abnormal Hemoglobins Detected by HPLC Screening

open access: yesTurkish Journal of Hematology, 2020
Duran Canatan   +4 more
doaj   +1 more source

From rumors to genetic isolates

open access: yesGenetics and Molecular Biology, 2014
Here we propose a registration process for population genetic isolates, usually geographic clusters of genetic disorders, based on the systematic search of rumors, defined as any type of account regardless of its reliability.
Eduardo E. Castilla   +1 more
doaj   +1 more source

Integrated analysis of variants and pathways in genome-wide association studies using polygenic models of disease [PDF]

open access: yesarXiv, 2012
Many common diseases are highly polygenic, modulated by a large number genetic factors with small effects on susceptibility to disease. These small effects are difficult to map reliably in genetic association studies. To address this problem, researchers have developed methods that aggregate information over sets of related genes, such as biological ...
arxiv  

Cystinuria: biochemical evidence for three genetically distinct diseases. [PDF]

open access: bronze, 1966
Leah Rosenberg   +3 more
openalex   +1 more source

Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI)

open access: yesJournal of Assisted Reproduction and Genetics, 2021
A. La Marca, E. Mastellari
semanticscholar   +1 more source

On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study

open access: yesMolecular Oncology, EarlyView.
The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy